Metabolomics Technologies Market By Application, By End User, By Type, Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jan 31, 2016

Key findings

 

The Global Metabolomics Technologies Market is expected to grow at the CAGR of XX% during 2015-2022 and it estimated to be $XX billion by 2022. The Global Metabolomics Technologies Market is majorly driven by growing biotechnology and pharmaceutical sectors. Government support for research and development is driving the market and expected to grow significantly in the next few years. Global adoption of Metabolomics technology in developed and emerging economies has created huge scope in the market. Global Metabolomics Technologies Market by applications such as Biomarker discovery, Drug discovery and development and so on is creating huge scope. The most common reason why companies are entering Global Metabolomics Technologies Market is the significant development in personalized medicines and drug discovery & development domains.

 

Global Metabolomics Technologies Market by technique such as Gas Chromatography, Capillary Electrophoresis, High Performance Liquid Chromatography, and Ultra Performance Liquid Chromatography and so on enables the companies to explore more in the market. As a result there is significant rise in revenues compared to past. It enables the Global Metabolomics Technologies Market to attract other major players to enter into the market in coming years. Emerging economies such as India, China, Japan and Korea are expected to contribute significantly in the next few years.

 

The Global Metabolomics Technologies Market companies such as Global Metabolomics Technologies Market. Agilent technologies, Thermo fisher scientific, Biocrates Life Sciences AG, Bruker Corporation, Danaher Corporation, Human Metabolomics Technologies, Inc, Leco Corporation, Metabolon, Inc, Shimadzu Corporation, Waters corporation, Avacta group PLC, Merc & Co. inc, Avid radiopharmaceuticals Inc, Banyan biomarkers, Diagenic ASA, Exonhit therapeutics, Genenews ltd, Glycominds ltd, Great lakes neurotechnologies, Innogenetics biological, innovative neurotechnologies Inc are constantly focusing on innovation and technological advancement. Also with increasing competition in the market companies are focusing on mergers and acquisition, partnership, collaboration, expansion and launching of new products.

 

Market segment insight

 

The application market for Global Metabolomics Technologies Market is segmented on the basis of application, technique, indication and geography. The major segment in Global Metabolomics Technologies Market is by application which includes Biomarker discovery, Drug discovery and development, Toxicology testing, Nutrigenomics and so on.

 

Regional insight

 

Globally, North America dominates the Global Metabolomics Technologies Market with high investments from manufacturers due to growing demand. However, North America is expected to contribute more than 45% market share followed by Europe and APAC. Both the regions are expected to create significant opportunities for the growth of the market during the forecasted years. Growing demand of Global Metabolomics Technologies Market in emerging economies are the major drivers.

 

Competitive insight

 

The key players in the Global Metabolomics Technologies Market include as Agilent technologies, Thermo fisher scientific, Biocrates Life Sciences AG, Bruker Corporation, Danaher Corporation, Human Metabolomics Technologies, inc, Leco Corporation, Metabolon, inc, Shimadzu Corporation, Waters corporation, Avacta group PLC, Merc & Co. inc, Avid radiopharmaceuticals Inc, Banyan biomarkers, Diagenic ASA, Exonhit therapeutics, Genenews ltd, Glycominds ltd, Great lakes neurotechnologies, Innogenetics biological, innovative neurotechnologies inc and so on. Mergers and Acquisition is the key strategy adopted in the Global Metabolomics Technologies Market to stay competitive. Also companies are adopting mergers and acquisition as strategy to stay competitive and partnerships to reach masses and explore the market.

 

Reasons for buying the report

 

  • This report provides a detailed study of current trends in the Global Metabolomics Technologies Market, key growth drivers, and restraints.
  • It provides market forecast for the next 7 years (2015-2022) assessed on the basis of market growth.
  • The report also includes analysis of recent technological developments in the Global Metabolomics Technologies Market, analysis of key market players and the key winning strategy adopted and predictive analysis.
  • The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
  • The report tracks and analyse the changing market dynamics.
  • The report also talks about emerging opportunities in the market and the future impact of major drivers and restraints of the market.
  • The report also provides extensive analysis with respect to key product segments.
  • The analysis in the report will help in making effective business decisions.
  • It provides analysis through distinctive graphs and charts and analyses strengths, weakness, opportunities and threats of major market players.

1. Methodology & Scope 9
    1.1. Research Methodology 9
    1.2. Research Scope & Assumptions 9
    1.3. List Of Data Sources 9

2. Executive Summary 10
    2.1. Global Metabolomics Technologies Market Summary & Key Buying Criteria 10
    2.2. Global Metabolomics Technologies Market Outlook 10

3. Market Segmentation 11
    3.1. Market Size And Growth Prospects 2012-2022 11
    3.2. Global Metabolomics Technologies Market Value Chain Analysis 11
    3.3. Vendor Landscape 11

4. Global Metabolomics Technologies Market 12
    4.1. Market Driver Analysis 12
        4.1.1. Development In Proteomics, Genomics And Imaging System Has Increased Demand For Cns Biomarker 12
        4.1.2. Funding From Government And Private Players To Boost Cns Biomarker Market 12
        4.1.3. Growth In Life Style Oriented Diseases 12
        4.1.4. Growth In Government And Private Funding In Cns Biomarker Market 12
        4.1.5. Fda Approvals To Boost The Market 12
    4.2. Market Restraint Analysis 12
        4.2.1. High Cost Of Cns Biomarker Test And Diagnostics 12
        4.2.2. Reimbursement Issues Affecting The Cns Biomarker Market 12
    4.3.1. Increasing Adoption Of Personalized Medicines 12
    4.3.2. Untapped Apac Region Has Huge Scope For Cns Biomarker Market 12
    4.3.3. Global Increase In Aging Population Has Created Huge Scope For Cns Biomarker Market 12
    4.3.4. Favorable Government Policies And Support For Cns Biomarkers 12

5. Industry Analysis – Porter’s 13
    5.1. Global Metabolomics Technologies Market– Pestel Analysis 13

6. Global Metabolomics Technologies Market By Application 2012-2022 ($ Billion) 14

7. Global Metabolomics Technologies Market By End User 2012-2022 ($ Billion) 15

8. Global Metabolomics Technologies Market, By Type 2012-2022 ($ Billion) 16

9. Global Metabolomics Technologies Market Regional Outlook 2012-2022 ($ Billion) 17
    9.1. Global Market Volume Share By Region 2012-2022 ($ Billion)
    9.2. North America
        9.2.1. North America Market Estimates And Forecast 2012-2022 ($ Billion)
        9.2.2. North America Market Estimates And Forecast By Region 2012-2022 ($ Billion)
        9.2.3. North America Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.2.3.1. U.S.
                9.2.3.1.1. U.S. Market Estimates And Forecast 2012-2022 ($ Billion)
                9.2.3.1.2. U.S. Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.2.3.2. Canada
                9.2.3.2.1. Canada Market Estimates And Forecast 2012-2022 ($ Billion)
                9.2.3.2.2. Canada Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.2.3.3. Mexico
                9.2.3.3.1. Mexico Market Estimates And Forecast 2012-2022 ($ Billion)
                9.2.3.3.2. Canada Market Estimates And Forecast By Application 2012-2022 ($ Billion)
    9.3. Europe
        9.3.1. Europe Market Estimates And Forecast 2012-2022 ($ Billion)
        9.3.2. Europe Market Estimates And Forecast By Region 2012-2022 ($ Billion)
        9.3.3. Europe Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.3.3.1. Germany
                9.3.3.1.1. Germany Market Estimates And Forecast 2012-2022 ($ Billion)
                9.3.3.1.2. Germany Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.3.3.2. Uk
                9.3.3.2.1. Uk Market Estimates And Forecast 2012-2022 ($ Billion)
                9.3.3.2.2. Uk Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.3.3.3. Russia
                9.3.3.3.1. Russia Market Estimates And Forecast 2012-2022 ($ Billion)
                9.3.3.3.2. Russia Market Estimates And Forecast By Application 2012-2022 ($ Billion)
    9.4. Asia Pacific
        9.4.1. Asia Pacific Market Estimates And Forecast 2012-2022 ($ Billion)
        9.4.2. Asia Pacific Market Estimates And Forecast By Region 2012-2022 ($ Billion)
        9.4.3. Asia Pacific Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.4.3.1. China
                9.4.3.1.1. China Market Estimates And Forecast 2012-2022 ($ Billion)
                9.4.3.1.2. China Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.4.3.2. India
                9.4.3.2.1. India Market Estimates And Forecast 2012-2022 ($ Billion)
                9.4.3.2.2. India Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.4.3.3. South Korea
                9.4.3.3.1. South Korea Market Estimates And Forecast 2012-2022 ($ Billion)
                9.4.3.3.2. South Korea Market Estimates And Forecast By Application 2012-2022 ($ Billion)
    9.5. Middle East & Africa
        9.5.1. Middle East & Africa Market Estimates And Forecast 2012-2022 ($ Billion)
        9.5.2. Middle East & Africa Market Estimates And Forecast By Application 2012-2022 ($ Billion)
    9.6. Central & South America
        9.6.1. Central & South America Market Estimates And Forecast 2012-2022 ($ Billion)
        9.6.2. Central & South America Market Estimates And Forecast By Application 2012-2022 ($ Billion)
            9.6.2.1. Brazil
                9.6.2.1.1. Brazil Market Estimates And Forecast 2012-2022 ($ Billion)
                9.6.2.1.2. Brazil Market Estimates And Forecast By Application 2012-2022 ($ Billion)

10. Competitive Landscape 20
    10.1. Thermo Fisher Scientific 21
    10.2. Abiant Inc 21
    10.3. Enzo Biochem Inc 21
        10.3.1. Company Overview 21
        10.3.2. Financial Performance 21
        10.3.3. Product Benchmarking 21
        10.3.4. Strategic Initiatives 21
    10.4. Acumen Pharmaceuticals Inc 21
        10.4.1. Company Overview 21
        10.4.2. Financial Performance 21
        10.4.3. Product Benchmarking 21
        10.4.4. Strategic Initiatives 21
    10.5. Adlyfe Inc 22
        10.5.1. Company Overview 22
        10.5.2. Financial Performance 22
        10.5.3. Product Benchmarking 22
        10.5.4. Strategic Initiatives 22
    10.6. Alseres Pharmaceuticals Inc 22
        10.6.1. Company Overview 22
        10.6.2. Financial Performance 22
        10.6.3. Product Benchmarking 22
        10.6.4. Strategic Initiatives 22
    10.7. Apitope International 22
        10.7.1. Company Overview 22
        10.7.2. Financial Performance 22
        10.7.3. Product Benchmarking 22
        10.7.4. Strategic Initiatives 22
    10.8. Aposense 22
        10.8.1. Company Overview 22
        10.8.2. Financial Performance 22
        10.8.3. Product Benchmarking 22
        10.8.4. Strategic Initiatives 22
    10.9. Applied Neurosolutions Inc 22
        10.9.1. Company Overview 22
        10.9.2. Financial Performance 22
        10.9.3. Product Benchmarking 22
        10.9.4. Strategic Initiatives 22
    10.10. Avacta Group Plc 22
        10.10.1. Company Overview 22
        10.10.2. Financial Performance 23
        10.10.3. Product Benchmarking 23

 

Table # 1 Global Metabolomics Technologies Market By Application 2012-2022 ($ Billion) 25

Table # 2 Global Diagnostic Development Market 2012-2022 ($ Billion) 25

Table # 3 Global Drug Discovery And Development Market 2012-2022 ($ Billion) 25

Table # 4 Global Personalized Medicine Market 2012-2022 ($ Billion) 26

Table # 5 Global Disease Risk Assessment Market 2012-2022 ($ Billion) 26

Table # 6 5.1.1.5. Global Other Market 2012-2022 ($ Billion) 26

Table # 7 Global Metabolomics Technologies Market By End User 2012-2022 ($ Billion) 26

Table # 8 Global Hospital Market 2012-2022 ($ Billion) 26

Table # 9 Global Eye Clinics Market 2012-2022 ($ Billion) 26

Table # 10 Global Diagnostic Centers Market 2012-2022 ($ Billion) 26

Table # 11 Global Patients Market 2012-2022 ($ Billion) 26

Table # 12 Global Other Market 2012-2022 ($ Billion) 26

Table # 13 26

Table # 14 Global Metabolomics Technologies Market, By Type, 2015-2022($ Billion) 26

Table # 15 5.1.2.1. Global Safety Biomarker Market 2012-2022 ($ Billion) 26

Table # 16 5.1.2.2. Global Efficacy Biomarker Market 2012-2022 ($ Billion) 26

Table # 17 5.1.2.2.1. Global Predictive Biomarker Market 2012-2022 ($ Billion) 26

Table # 18 5.1.2.2.2. Global Pharmacodynamic Biomarker Market 2012-2022 ($ Billion) 26

Table # 19 5.1.2.2.3. Global Prognostic Biomarker Market 2012-2022 ($ Billion) 26

Table # 20 5.1.2.3. Global Validation Biomarker Market 2012-2022 ($ Billion) 26

Figure # 1 Market Share By Regions 27

Figure # 2 United States Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 3 Canada Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 4 Mexico Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 5 Uk Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 6 France Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 7 Germany Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 8 Apac Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 9 China Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 10 India Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 11 Middle East & Africa Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 12 Central & South America Market Estimates And Forecast 2012-2022 ($ Billion) 27

Figure # 13 Brazil Market Estimates And Forecast 2012-2022 ($ Billion) 27

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)